





1200-73 Central Pulse Pressure and Proximal Aortic Stiffness 
Remain Unchanged During the Normal Human 
Menstrual Cycle 
Nadia O. Skali. Gary F. Mitchell, Caren G. Solomon, Ellen W. Seely, Brigham and 
Women's Hospital, Boston, Massachusetts, Cardiovascular Engineering Inc., Holliston, 
Massachusetts. 
Background: Both Estradiol (E) and endogenous Progesterone (P) have vasodilator 
effects. Despite the marked differences in their levels in the follicular and luteal phases of 
the normal menstrual cycle (MC), studies have shown no difference in brachial blood 
pressure (BP) between the two phases. This suggests that, either the vasodilation is only 
seen centrally or there is compensatory activation of the renin-angiotensin system (RAS). 
This study was designed to investigate central arterial changes and RAS activity in 
response to gonadal steroids variations during the MC. 
Methods: We studied 13 healthy women (mean age: 29 ± 4 years) during the follicular 
(day 2 to 5), and luteal (day 18 to 24) phases of the MC. All women had regular MCs and 
none were taking oral contraceptives. Ovulation was confirmed by a luteal rise in P (P 
>5pg/ml), E and P, total renin, prorenin and active ranth were determined at each phase. 
Central pulsatile hemodynamics were evaluated using calibrated carotid tonometry and 
central aortic Doppler flow. Two seated brachial BPs were measured by an automatic 
monitor and averaged. 
Reaulte: 
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Follicular phase Luteal phase P 
Progesterone (pg/ml) 0.6 ± 0.3 11.6 ± 4.1 <0.001 
Estradiol (pg/ml) 33.6_+9.1 126.3+43.3 <0.001 
Total Renin (llu/ml) 124.0 ± 52.7 225.9 ± 80.8 <0.001 
Prorenin (pu/ml) 120.8 ± 48.0 198.8 ± 71.6 <0.001 
Active Renin (p.u/ml) 10.7 ± 5.8 27.6 ± 16.6 <0.01 
Aldosterone (ng/ml) 8,2 _+ 7.0 18.0 ± 6.7 <0.001 
Peripheral Systolic BP (mmHg) 109 ± 8 106 ± 10 0.52 
Peripheral Diastolic BP(mmHg) 67 ± 8 66 ± 6 0.60 
Peripheral Pulse Pressure (mmHg) 42 +_ 6 41 _+ 9 0.6 
Central Systolic BP(mmHg) 99 ± 11 99 ± 11 0.8 
Central Diastolic BP (mmHg) 57 ± 6 57 ± 7 1 
Central Pulse Pressure (mmHg) 42 ± 9 41 ± 9 0.8 
Characteristic Impedance Zc (dynes * s/cm 5) 179 ± 44 183 ± 64 0.8 
Augmentation Index (%) 7.7 ± 8.9 7.2 ± 10.2 0.3 
Carotid Femoral Pulse Wave Velocity (m/s) 5.4 ± 0.6 5.6 ± 0.8 0.3 
Conclusion: Central arterial stiffness and both peripheral and central BPs did not differ 
between the follicular and the luteal phases of the MC, despite the significant changes in 
levels of endogenous E and P. These null findings may reflect a vasoconstrictive ffect 
from activation of the RAS that offsets the vasodilatory effect of increased levels of E and 
P during the luteal phase of the menstrual cycle. 
1200-74 Weight Loss Does Not Alter Sympathetically-Mediated 
Vascular Tone in Normotensive Obese Humans 
Alexei V. Aaaoitov. Marcelo L. Correia, John M. Dopp, Christine A. Sinkey, Bradley G. 
Phillips, William G. Haynes, University of Iowa, Iowa Ci~ Iowa. 
Background: Obesity is associated with sympathoactivation, as assessed by micron- 
autographic muscle sympathetic nerve activity (MSNA). Weight loss has been shown to 
decrease MSNA. However, it is unclear whether MSNA reflects sympathetic vascular 
tone. 
Methods: Forearm vascular resistance (FVR) responses to intrabrachial phentolamine 
(120 I~g]min; sufficient o block vasoconstriction to norepinephrine) were used to evaluate 
the sympathetic ontribution to basal vascular tone in 19 obese normotensive subjects (4 
males; 39±2 yr) and 14 age and gender.matched lean subjects (3 males; 39±2 yr). Nitre- 
prusside (10 pg/min) was used to evaluate vascular smooth muscle dilator responsive- 
ness. Measurements were repeated in all obese subjects after 12 weeks of hypocaloric 
diet and orlistat treatment and in 8 lean subjects after 12 weeks of observation with no 
treatment. 
Results: Baseline MSNA was significantly higher in obese than lean subjects, but phen- 
tolamine responses were similar. The hypocalodc diet significantly reduced body mass 
index (BMI), blood pressure and MSNA (table; *p<0.05 vs obese baseline). However, no 
significant effects of weight loss on vasodilatation to phentolamine and nitroprusside 
were observed. No significant changes were observed in lean subjects after 12 weeks. 
Conclualon: Elevated MSHA in normotensive obese subjects, and decreases in MSNA 
with weight loss, do not translate into alterations in sympathetically-mediated vascular 
tone. 
BMI Daytime mean Baseline NitroprussidePhentolamine MSNA 
(kg/m 2) ambulatory blood FVR (% ~. FVR) (% Z~ FVR) (bursts per 
pressure (mm Hg) minute) 
91±2 3.3±0.2 -80±2 -58±4 22±1" 
92±1 2,7±0.2 -75±2 -58±2 30±4 
89 ±1" 2.6±0.2 -72±2 -57±3 24±3* 





Obese after 32±1" 
weight loss 
1200-75 Determinants of Coronary Artery Compliance in 
Subjects With and Without Angiogrephic Coronary 
Artery Disease 
James A. Shaw. Anthony S. Walton, Bronwyn A. Kingwelt, James D. Cameron, Anthony 
M. Dart, Alfred Hospital and Baker Medical Research Institute, Melbourne, Australia, 
Massachusetts General Hospital, Boston, Massachusetts, Australia. 
Objectives: To determime the factors contributing to the biomechanical properties of cor- 
onary arteries in people with and without angiographic oronary disease. 
Background: The stiffness of the aorta is known to increase with increasing age and in 
the presence of coronary artery disease. However little is known about the mechanics of 
coronary arteries which may have important clinical consequences. 
Methods: Intravascular ultrasound was used to determine the mechanical properties and 
plaque behavior in subjects with coronary artery disease (CAD) (n=38), those with chest 
pain but angiogrephically normal coronary arteries (Nx) (n=9) and those early (<2 weeks) 
post cardiac transplant (Tx) (n=t4). 
Results: Coronary arteries dilated during systole in all groups but cross-sectional compli- 
ance and distensibility were less in the proximal LAD in the CAD compared with the Nx 
and Tx group (Compliance; 1.2±0.2 x 10-2 vs 1.7¢0.5 x 10-2 and 2.7±0.6 x 10-2 ram2 / 
mmHg (mean±sam) respectively, p<0.01 CAD vs Tx. Distensibility: 0.8±0.2 x 10-3 vs 
1.7±0.5 x10-3 and 1,7±0.3 x 10-3 mmHg -1, p<0.05 CAD vs Nx and Tx). Differences 
between CAD and Nx groups remained significant following adjustment for age. There 
was extensive plaque in the CAD group that correlated negatively with the lumen area 
(r2=0.58, p<0.001) but minimal atheroma was present in the Tx group. In the CAD group 
plaque cross-sectional area diminished significantly during systole in both the LAD and 
circumflex arteries. Absolute changes were: 0.50¢ 0.30, 0.33±0.11 and 0.68±0.13mm2 in
the proximal, distal LAD and proximal circumflex artery respectively. At both proximal 
sites this reduction was a significant determinant of cross-sectional compliance. 
Conclusion: CAD patients have reduced coronary compliance and distensibility com- 
pared with patients with chest pain and angiographically normal arteries and those early 
post cardiac transplant. Mechanical properties of 'angiographically normal' segments of 
coronary artery thus depend both on age and the presence of atheromatous plaque, 
1200-76 Obesity Is Associated With Increased Conduit Vessel 
Stiffness in a Community-Based Cohort: The NHLBI 
Framingham Heart Study 
Gary F. Mitchell. Emelia J. Benjamin, Michelle J. Kupka, Martin G. Larson, Daniel Levy, 
Cardiovascular Engineering, Inc., Hol/iston, Massachusetts, Boston University School of 
Medicine, Boston, Massachusetts. 
Background: Obesity is associated with insulin resistance and systolic hypertension, 
which are related to conduit stiffness. Prior studies of anthropometdcs and conduit vessel 
stiffness in various disease states have reported associations between vessel stiffness 
and height, weight and body-mass index (BMI). However, no prior study has assessed 
these relations in a large community-based cohort. 
Methods: We evaluated anthropometrics and vessel stiffness by assessing carotid-fem- 
oral pulse wave velocity (PWV) in 820 subjects attending a routine exam at the Framing- 
ham Study. PWV was determined from sequential tonometry of the femoral and carotid 
arteries using the ECG as a fiducial point. 
Reaulte: Mean characteristics of the cohort included age 62±9 (range 37-86) years and 
PWV 10.5±3.8 m/s; 55% were female. Linear regression with age, gender and height, 
weight or BMI demonstrated that PWV was associated with increasing weight and BMI 
(Table), but not height, The relations persisted after adjustment for current systolic blood 
pressure. 
Table. Change in PWV (m/s) per SD change in predictor variable. 
Predictor Mean SD [3 195% C I} P 
Weight (kg.) 764 13.3 0.47 (0.25.-0.69) 0.0001 
BMI (kghn') 27.2 4.4 0.50 (0.28-0.72) 0.0001 
Conclusion: In this large community-based cohort, obesity is associated with stiffer cen- 
tral conduit vessels, which may contribute to increasing systolic blood pressure and 
increased risk for cardiovascular events. Insulin resistance, which is common in obese 
adults, may mediate the increase in conduit vessel stiffness, providing a potential ink 
between obesity, insulin resistance and systolic hypertension. 
1200-77 Slow Flow on Distal Left Anterior Descending Coronary 
Artery Demonstrated by Transthoracic Doppler 
Echocardiography Predicts Pathologic Coronary Flow 
Dynamics 
Ho-Joong Youn, Hui-Kyung Jean, Eun-Joo Cho, Yong-Seok Oh, Wook-Sung Chung, 
Jae-Hyung Kim, Kyu-Bo Choi, Soon-Jo Hang, The Catholic University of Korea, Seoul, 
South Korea. 
Purpose :The aim of this study was to test whether transthoracic Doppler echocardiography 
can predict he pathologic flow of left anterior descending coronary artery (LAD). 
Methods : We prospectively examined 200 subjscts(age 56±12 yrs, M:F=123:77) underwent 
coronary angiogrem. After obtaining the tubular color flow signals of distal LAD using an ultra- 
band transducer (5-12 MHz) with a special preset program of a low velocity range, the peak 
diastolic velocity (PDV) was measured. 
Results: 1. Retrograde flow was detected in 8 of 12 patients(67%) with TIMI 0 and TIMI 1 flow 
with collateral vessels. 2. PDV was 13.4±5.5 cm/sec in subjects with TIMI 1 flow, 
15.1±6.8cnVssc in subjects with TIMI 2 flow and 22,1±11.8 cnVsec in subjects with TIMI 3 
flow(p<0.01 versus TIMI 1 and 2 flow, respectively). 3. PDV of less than 13 cm/sec had sen- 
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sitivity of 58% and specificity of 91% for identifying lesion type B2+C by ACC/AHA guide line. 
Conclusion: Direction and velocity of baseline coronary flow using transthoracic Doppler 
echocardiography provide clinically valuable informations about the condition of coronary 
artery. Especially, slow flow predicts the pathologic flow dynamics of coronary art~des. 
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1201-79 Long-Term Prognostic Value of Triiodothyronine 
Concentration in Elderly Patients With Stable Heart 
Fai lure 
Jairo Rays, Mauricio Wajngarten, Otavio E. Gebara, Amit Nussbecher, Joao Batista 
Serro Azul, Humberto Pierri, Heart Institute, S~o Paulo, Brazil. 
Background : Heart Failure (HF) is very prevalent in eidedy patients. Low total triiodothyro- 
nine (T3), with normal free thyroxine (FT4) and thyroid stimulating hormone (TSH) concen- 
trations is frequent and has prognostic value in severely ill patients. However, this hormonal 
milieu has not been studied in elderly patients with stable HIE Objective: To investigate the 
prognostic value of T3 concentration in elderly patients with stable HF and without thyroid 
disease. Methods : We evaluated 69 elderly patients with stable NYHA class II-lll HF, with 
FT4 and TSH within normal range. Patients were followed by an average of 14±8 months 
and had T3 concentration analyzed. 44 age matched subjects without ventricuier dysfunc- 
tion formed the control group. Results : HF patients had significantly lower T3 concentration 
than controls (89±23 vs 101±16 ng/dl, p-~.0098). Among HF patients that died, T3 concen- 
tration was lower than of those who survived (79.t.22 vs 93¢2.3 ng/dl, p=0.03). Furthermore, 
mortality was higher in patients with levels of T3 bower than 80ng/dl (figure). The adjusted 
odds.ratio for cardiovascular events (hospitalization and/or death) was 9.8 (95% CI 2.2 to 
43.0; p=0.004) for patients with T3 concentration lower than 80ng/dl versus those with T3 
between 80 and 100 rig/d1. Conclusion : In eldedy patients with stable HF and without thy- 
roid disease, T3 concentration lower than 80ng/dl is associated with worse prognosis. T3 
values should be included in the routine evaluation of this population. 
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1201-80 The Predictive Value of Combinations of Different 
Levels of Brain Natr iuret ic  Pept ide and Norepinephrine 
in the  VaI -HeFr  Trial 
Inderiit S. Anand. Roberto Latini, Serge Masson, Dienne Judd, Aido P. Maggioni, Robert 
Glazer, Tom Chiang, Philippe Lechat, Gianni Tognoni, Jay N. Cohn, on the behalf of the 
VaI-HeFT Investigators, VA Medical Center and University of Minnesota, Minneapolis, 
Minnesota, Istituto di Ricerche Farmacologiche, Milan, Italy: 
Background: Plasma brain natriuretic paptide (BNP) and plasma norepinephrine (NE) 
are important markers of the severity and prognosis of heart failure (HF). Whether any 
combination of BNP and NE has additional prognostic value has never been reported. 
Methods and Results: The VaI-HeFT trial evaluated the efficacy of the angiotensin 
receptor blocker valsartan in 5010 patients with HF, and measured BNP and NE at base- 
line. Patients were stratified based on background beta-blocker (BB) therapy. 93% 
patients were receiving ACE-I and 35 % BB at baseline. BNP and NE (both in pg/mL) 
were measured in core labs. The mortality risk was calculated in various combinations 
depending on the median value of BNP (97 pg/mL) and NE (394 og/mL), with BNP and 
NE defined as high (->) or low (<) for values above and below the median. As expected, 
high values of BNP or NE were associated with a significantly higher mortality. The risk 
ratios for various combinations of BNP and NE in order of magnitude are shown in the 
Table. Conclusions: Whereas both plasma BNP and NE are significant prognostic mark- 
ers in HF, plasma BNP is the stronger of the two. High NE contributes greater prognostic 
value in the presence of high than low BNP. 
*RR from Cox proportional hazard model; **p-value calculated from Io~ rank dest 
Subgroup Comparison Group 1 (n) Group2 (n) Risk Ratio* 95 % C.I. p-value** 
_>BNP vs <BNP 2171 2134 2.08 1.79, 2.42 <0.0001 
>NE vs <NE 2151 2150 1.48 1.28, 1.71 <0.0001 
_>BNP + >NE vs <BNP + <NE 1223 1206 2.79 2.25,3.47 <0.0001 
_>BNP + <NE vs <BNP + <NE 935 1206 1.93 1.54, 2.43 <0.0001 
<BNP + ->NE vs <BNP + <NE 920 1206 1.27 0.99, 1.63 0.0056 
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1201-81 N-Terminal Pro Brain Natrlureti¢ Peptide (NT-proBNP) 
Predicts Left Ventriculer Function and Mortality in 
Hemodlalysis Patients but Not Cardiac Death: A Two- 
Year Outcome Study 
Joseoh P. Lonohitano. William L. Henhch, Paul D. Light, Eric Tiblier, Heidi Sparger, 
Mathew M. Smilay, John Badalamenti, Juergen Trawinski, Christopher R. deFilippi, 
University of Maryland, Baltimore, Maryland, University of Texas Medical Branch, 
Galveston, Texas. 
NT-proBNP is a stable marker of left ventricular (LV) dysfunction in the general popula- 
tion, but its predictive value in patients on chronic hemodialysis (HD), a group with 
chronic volume overload as well as a large burden of ischemic heart disease and cardio- 
vascular death, is unknown. This prospective study of 224 HD patients was designed to 
learn the predictive value of NT-proBNP for death, LV function and the magnitude of 
CAD. HD pts from 5 HD centers (age 60±15 years, 54% male, 48% diabetic) in whom 
NT-proBNP levels (mean of two values, one month apart, normal <70 pmol/L, Roche 
Diagnostics), LVEF and LV mass (measured by echocardiography in 155 of 224 pts) 
were quantified. For the 77 pts who died during the 2 year fonow-up, NT-proBNP levels 
were significantly higher than in those who lived (7027±8660 vs. 4613+5921, p=0.015). 
For the 24 pts with LVEF_< 0.40, NT-preBNP levels were higher than pts with LVEF >0.40 
(9956±11420 vs. 4853±5940, p=0.0013). The Table depicts NT-proBNP by quartiies, and 
shows the corresponding mortality (%), depressed LVEF (%), mean LV mass, multives- 
sel CAD (%) and cardiac death or non-fatal MI (%). Overall mortality, LV dysfunction and 
LV mass increased with risifig NT-proBNP levels but NT-proBNP was not predictive of 
multivessel CAD or cardiac death. 
We conclude that NT-proBNP levels are high in most HD pts, and that levels >2800 pmol/ 
L are associated with a marked decrease in LVEF and risk of all cause mortality in a large 
percentage of pts but are not a marker of atheroscierotic burden or CV death, 
Quartile 1 Quartile 2 Quartile 3 Quartile 4 pvaluefortrend 
NT-proBNP (pmol/L) 87-1246 1247-27662792-66986730-55164 
Death (% pts) 23.2 23.2 46.4 44.6 0.006 
LVEF< 0.40 (% pts) 2.6 9.8 22.6 27.3 0.008 
LV mass (g/m 2) 130-~31 133+31 137±44 160±39 0.002 
Multivessel CAD (% pts) 42.1 18.1 5.6 47.6 0.790 
CV Death or Non-Fatal MI 16.1 17.9 16.1 22.6 0.450 
(% pts) 
1201-82 Effect of Combined Hormone Replacement Therapy on 
Thrombotic and Fibrinolytic Potentials and Lp(a) Levels 
in Elderly Women 
Otavio C. Gebara, Margareth Venturinell, Jose M. Aldrighi, Nubia Vieira, Amit 
Nussbacher, Humberto Pierri, Serro-Azul Jo~o, Elbio D'Amico, Mauricio Wajngarten, 
Giuseppe Rosano, Jose A. Ramiras, Heart Institute from the Medical School University 
of S~o Paulo, Sao Paulo, Brazil, Instituto San Raffaelle, Rome, Italy: 
Background: Eldedy women are are potential candidates for postmenopausal hormone 
replacement herapy (HRT). This therapy, however, may increase their risk of thrombotic 
cardiovascular events. To date, the impact of HRT on coagulation, fibrinolysis, and levels 
of lipoprotein (a) [Lp(a)] is not fully understood in this population. 
Method~ In a double-blind, placebo-controlled study, 17 women older than 65 years 
(mean age 70_+4 yrs),without cardiovascular disease,received for a period of 60 days 
either HRT (oral conjugated estrogens 0,625 mg/d plus medrexyprogesterone acetate 
2,5mg/d) or placebo. At the and of each treatment phase, we measured variables that 
express a pro-thrombotic state (fibdnogen, factor VII, vonWillebrand factor [vWF], anti- 
thrembin III [ATIII], Protein C), or that express activation of coagulation (thrombin-anti- 
thrombin complex[TAT] and fragment 1+2[F1.2] ), and variables that show activation of 
fibrinolysie (t-PA activity [t-PAac], t-PA antigen, t-PA inhibitor [PAl-l], Lp(a) and D-dimar). 
Conclusion: HRT in elderly women increased markers of thrombosis and increased the 
fibdnolytic potential. The clinical significance of these opposing effects should be evalu- 
ated in prospective studies and may be important in better selecting candidates for long- 
term treatment. 
Results: HRT Placebo P 
Fibrinogen (mg/dl) 326+79 315+64 0.618 
Factor VII (%) 136+45 151+39 0.250 
vWF (%) 117+ 13 116+ 15 0.908 
ATIII (%) 143+35 139+30 0.672 
Protein C (%) 116+36 111+31 0.608 
TAT (mg/L) 4.7+2.1 3.4+0.9 0.016 
F1+2 (nmol/L) 3.0+2.8 1.4+0.6 0.018 
t-PAac (UI/mL) 43+13 34+9 0.001 
t-PAag (ng/ml) 5.6+1.6 6.5+1.7 0.014 
PAl-1 (ng/ml) 24.0+6.9 25.6+9.1 0.775 
D-dimer (ng/ml) 85+62 57+37 0.023 
Lp(a)(ng/ml) 19.1+14.5 29.0+22 0.025 
